Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,229 | 50,588 | 73,441 | 64,941 | 36,810 |
| Marketable Securities | 53,176 | 49,466 | N/A | N/A | N/A |
| Receivables | 120,110 | 54,120 | 47,663 | 45,357 | 44,361 |
| Inventories | 24,120 | 38,308 | 37,686 | 13,696 | 7,489 |
| TOTAL | $216,646 | $202,549 | $171,062 | $132,262 | $103,498 |
| Non-Current Assets | |||||
| PPE Net | 444 | 586 | 770 | 744 | 1,527 |
| Intangibles | 48,908 | 80,471 | 111,332 | 197,996 | 216,054 |
| Other Non-Current Assets | 972 | 1,126 | 3,255 | 82,911 | 5,468 |
| TOTAL | $50,324 | $82,183 | $115,357 | $281,651 | $223,049 |
| Total Assets | $266,970 | $284,732 | $286,419 | $413,913 | $326,547 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 470 | 12,174 |
| Accounts payable and accrued liabilities | 9,014 | 14,736 | 13,439 | 5,991 | 6,685 |
| Accrued Expenses | 113,648 | 95,151 | 76,350 | 61,607 | 67,361 |
| Other current liabilities | 4,851 | 4,801 | 3,654 | 27,248 | 48,799 |
| TOTAL | $127,513 | $114,688 | $93,443 | $95,316 | $135,019 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,124 | 38,813 | 38,514 | 66,403 | 61,319 |
| Other Non-Current Liabilities | 6,381 | 10,150 | 16,459 | 26,469 | 27,795 |
| TOTAL | $45,505 | $48,963 | $54,973 | $92,872 | $89,114 |
| Total Liabilities | $173,018 | $163,651 | $148,416 | $188,188 | $224,133 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,445 | 6,388 | 6,336 | 3,707 | 3,024 |
| Common Shares | 1 | 1 | 9 | 5 | 4 |
| Retained earnings | -703,499 | -673,124 | -651,543 | -319,601 | -429,226 |
| TOTAL | $93,952 | $121,081 | $138,003 | $225,725 | $102,414 |
| Total Liabilities And Equity | $266,970 | $284,732 | $286,419 | $413,913 | $326,547 |